GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹3,606 Cr | ₹3,410 Cr | ₹2,798 Cr | ₹2,494 Cr | ₹3,708 Cr |
What is the latest Total Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2026 | ₹3,606 Cr |
| Mar2025 | ₹3,410 Cr |
| Mar2024 | ₹2,798 Cr |
| Mar2023 | ₹2,494 Cr |
| Mar2022 | ₹3,708 Cr |
How is Total Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,606 Cr | 5.76 | |
| Mar2025 | ₹3,410 Cr | 21.85 | |
| Mar2024 | ₹2,798 Cr | 12.19 | |
| Mar2023 | ₹2,494 Cr | -32.73 | |
| Mar2022 | ₹3,708 Cr | - | |
Compare Total Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹40,737.3 Cr | -6.3% | -16.3% | -10.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -6.3% |
-16.3% |
-10.8% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses